Differential	O
regulation	O
of	O
in	O
vivo	O
angiogenesis	O
by	O
angiotensin	O
II	O
receptors	O
.	O

Angiotensin	O
II	O
(	O
ANG	O
II	O
)	O
,	O
a	O
key	O
regulator	O
of	O
blood	B-Organism_substance
pressure	O
and	O
body	B-Organism_substance
fluid	I-Organism_substance
homeostasis	O
,	O
exerts	O
mitogenic	O
effects	O
on	O
endothelial	B-Cell
cells	I-Cell
.	O

We	O
therefore	O
hypothesized	O
that	O
ANG	O
II	O
could	O
be	O
a	O
mediator	O
between	O
homeostatic	O
changes	O
within	O
the	O
vascular	B-Multi-tissue_structure
perfusion	I-Multi-tissue_structure
bed	I-Multi-tissue_structure
and	O
growth	O
factor	O
-	O
driven	O
angiogenesis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
applied	O
the	O
alginate	O
implant	O
angiogenesis	O
model	O
in	O
mice	O
with	O
normal	O
ANG	O
II	O
levels	O
,	O
elevated	O
ANG	O
II	O
levels	O
by	O
transgenic	O
overexpression	O
of	O
angiotensinogen	O
(	O
AOGEN	O
)	O
,	O
or	O
in	O
AT2	O
receptor	O
-	O
deficient	O
mice	O
.	O

We	O
demonstrate	O
that	O
a	O
decrease	O
in	O
the	O
amount	O
of	O
circulating	O
ANG	O
II	O
by	O
the	O
angiotensin	O
-	O
converting	O
enzyme	O
(	O
ACE	O
)	O
inhibitor	O
enalapril	O
or	O
the	O
AT1	O
receptor	O
antagonist	O
losartan	O
induced	O
a	O
stimulation	O
of	O
in	O
vivo	O
angiogenesis	O
implying	O
an	O
inhibitory	O
function	O
of	O
ANG	O
II	O
through	O
the	O
AT1	O
receptor	O
.	O

However	O
,	O
the	O
strong	O
increase	O
of	O
angiogenesis	O
in	O
AOGEN	O
-	O
transgenic	O
mice	O
compared	O
with	O
mice	O
with	O
normal	O
ANG	O
II	O
levels	O
suggests	O
additional	O
stimulatory	O
activity	O
.	O

We	O
showed	O
that	O
the	O
ANG	O
II	O
-	O
induced	O
stimulation	O
of	O
angiogenesis	O
is	O
linked	O
to	O
the	O
AT2	O
receptor	O
as	O
an	O
impaired	O
induction	O
of	O
angiogenesis	O
was	O
obtained	O
in	O
AT2	O
receptor	O
knockout	O
mice	O
.	O

These	O
findings	O
provide	O
the	O
first	O
evidence	O
that	O
the	O
AT2	O
receptor	O
mediates	O
a	O
stimulation	O
of	O
in	O
vivo	O
angiogenesis	O
and	O
indicate	O
that	O
ANG	O
II	O
is	O
a	O
humoral	O
regulator	O
of	O
peripheral	O
angiogenesis	O
involving	O
two	O
receptor	O
subtypes	O
with	O
opposing	O
actions	O
.	O

